The 12 Hallmarks of Aging in Dogs, Explained
Read full insightBeta Glucans for Dogs
By La Petite Labs Editorial 14 min read
References
Numbered references identify the sources used for specific claims. Read the study design, species and evidence boundaries alongside each finding.
-
Fries-Craft K and colleagues. Dietary yeast beta 1,3/1,6 glucan supplemented to adult Labrador Retrievers alters peripheral blood immune cell responses to vaccination challenge without affecting protective immunity. Study design/context: Controlled feeding and vaccination studySpecies/context: Dogs (healthy adult Labradors)Evidence boundary: Yeast-glucan feeding changed selected immune-cell responses without improving protective antibody titers.↩
-
Stuyven E and colleagues. Oral Administration of β-1,3/1,6-Glucan to Dogs Temporally Changes Total and Antigen-Specific IgA and IgM. Study design/context: Two feeding experimentsSpecies/context: Dogs (healthy female Beagles)Evidence boundary: Oral yeast glucan temporarily shifted antibody classes in different directions.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Reactome. CLEC7A binds 1,3-beta-D-glucan. Study design/context: Curated receptor reactionSpecies/context: Human receptor biologyEvidence boundary: Curated Dectin-1 binding reaction; it explains recognition, not oral supplement efficacy.↩ 1 · ↩ 2 · ↩ 3
-
Stephanie de Souza Theodoro and colleagues. β-glucans from Euglena gracilis or Saccharomyces cerevisiae effects on immunity and inflammatory parameters in dogs. Study design/context: Four-diet feeding experimentSpecies/context: Dogs (healthy adult Beagles)Evidence boundary: Immune-cell uptake after dietary supplementation.↩ 1 · ↩ 2 · ↩ 3
-
Marchi PH and colleagues. Effects of Increasing Levels of Purified Beta-1,3/1,6-Glucans on the Fecal Microbiome, Digestibility, and Immunity Variables of Healthy Adult Dogs. Study design/context: Four-period crossover feeding studySpecies/context: Dogs (eight healthy adults)Evidence boundary: Small dose-ranging feeding study of microbiota, digestibility and immune markers.↩
-
Stephanie de Souza Theodoro and colleagues. Beyond Immunity: Functional Outcomes of Dietary Yeast and Seaweed β-Glucans in Adult Canine Nutrition. Study design/context: Gut outcomes from the 2024 feeding experimentSpecies/context: Dogs (same cohort as the 2024 source comparison)Evidence boundary: Gut and metabolic outcomes from the same dogs as the 2024 immune comparison.↩
-
Beynen AC and colleagues. Dietary Beta-1,3/1,6-Glucans Reduce Clinical Signs of Canine Atopy. Study design/context: Controlled diet trialSpecies/context: Dogs with atopyEvidence boundary: Owner-rated diet trial; no individual sign showed a significant between-group improvement.↩
-
Amaral AR and colleagues. Adverse Reactions to Yeast Beta-Glucan Supplementation in Two Dogs with Inflammatory Bowel Disease. Study design/context: Two-dog case reportSpecies/context: Dogs with IBD (case report)Evidence boundary: Two adverse-reaction cases after yeast-glucan supplementation; frequency and causative component remain uncertain.↩
-
Gedney A and colleagues. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma. Study design/context: Clinical treatment study; randomized chemotherapy comparisonSpecies/context: Dogs with splenic hemangiosarcomaEvidence boundary: Turkey-tail PSP did not add survival benefit to doxorubicin; this was not yeast-glucan supplementation.↩
-
Ferreira LG and colleagues. Oat beta-glucan as a dietary supplement for dogs. Study design/context: Controlled feeding studySpecies/context: Dogs (adult Beagles)Evidence boundary: Concentrated oat beta-glucan feeding study, with cereal-specific stool and digestibility outcomes.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Fletcher RS and colleagues. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Study design/context: Cell and animal experimentsSpecies/context: Mouse skeletal-muscle cells and miceEvidence boundary: NR/NMN metabolism in mouse muscle models; normal precursor biology, not a dog product trial.↩
-
Reactome. Complex I oxidises NADH to NAD+, reduces CoQ to CoQH2. Study design/context: Curated mitochondrial reactionSpecies/context: Human cellular pathwayEvidence boundary: Normal NADH-to-coenzyme-Q electron transfer; supplementation benefits were not tested.↩ 1 · ↩ 2
-
Reactome. GPX1 catalyzes 2 glutathione, reduced + H2O2 => glutathione, oxidized + 2 H2O. Study design/context: Curated enzyme reactionSpecies/context: Human cellular pathwayEvidence boundary: Normal glutathione-dependent peroxide handling; it does not establish oral delivery or clinical benefit.↩ 1 · ↩ 2
-
Amaral AR and colleagues. Microbiota in Mild Inflammatory Bowel Disease (IBD) Can Be Modulated by Beta-Glucans and Mannanoligosaccharides: A Randomized, Double-Blinded Study in Dogs. Study design/context: Randomized, blinded feeding trialSpecies/context: Dogs with mild IBDEvidence boundary: Microbiota findings in controlled IBD; clinical and stool scores did not improve.↩ 1 · ↩ 2
-
Reactome. CLEC7A (Dectin-1) signaling. Study design/context: Curated immune pathwaySpecies/context: Human innate-immune pathwayEvidence boundary: Dectin-1 signaling connects recognition to cell communication and engulfment; not a feeding trial.↩ 1 · ↩ 2 · ↩ 3
-
Hill C and colleagues. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Study design/context: Expert consensusSpecies/context: Expert consensus on probiotic terminologyEvidence boundary: Defines probiotics by living microorganisms and demonstrated benefit; not a canine efficacy trial.↩
Keep exploring
What would you like to understand next?
Search practical guides about healthy aging, cellular energy, ingredients, and daily support for dogs.

